This webinar was presented live on Wednesday, September 18, 2019. Click below to watch it on demand.
For device and IVD manufacturers, the negative consequences that are predicted from the European Union’s implementation of the new MDR and IVDR requirements in 2020 and 2022, respectively, have been widely publicized and appear daunting. This webinar will explore some of the upcoming challenges, benefits and six essential “musts” – from a clinical research point of view – that should be in everyone’s MDR survival guide in order to successfully navigate the complexities inherent in this change.
By attending this webinar, you will be able to:
- Identify at least 3 challenges inherent in the new MDR and IVDR requirements.
- Describe the overall purpose and potential positive impact of the new MDR and IVDR requirements.
- List six essential strategies for navigating the clinical evidence expectations of the new MDR and IVDR requirements.
Featured Speakers:
Sandra Maddock
CEO
IMARC Research, Inc.
CEO
IMARC Research, Inc.
Brandy Chittester
President
IMARC Research, Inc.
President
IMARC Research, Inc.
Danielle KirshAssociate Editor
Medical Design and Outsourcing
Sponsored By:
